These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7065741)

  • 1. The incidence of malignant disease in patients receiving cytotoxic therapy for rheumatoid arthritis.
    Kirsner AB; Farber SJ; Sheon RP; Finkel RI
    Ann Rheum Dis; 1982; 41 Suppl 1(Suppl 1):32-3. PubMed ID: 7065741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative incidence of malignant disease in rheumatoid arthritics exposed to different treatment regimens.
    Hazleman BL
    Ann Rheum Dis; 1982; 41 Suppl 1(Suppl 1):12-7. PubMed ID: 7039526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens.
    Hazleman B
    Am J Med; 1985 Jan; 78(1A):39-43. PubMed ID: 3970039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer and immunosuppressive treatment. Apropos of 2 cases].
    Le Goff P; Le Menn G
    Sem Hop; 1974 Feb; 50(10):657-63. PubMed ID: 4366161
    [No Abstract]   [Full Text] [Related]  

  • 5. [Malignant affections occurring in rheumatoid arthritis].
    Treves R
    Presse Med; 1991 Apr; 20(13):583-4. PubMed ID: 1827901
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of malignancy in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under immunosuppressive therapy: a single-center experience.
    Fantò M; Peragallo MS; Pietrosanti M; Di Rosa R; Picchianti Diamanti A; Salemi S; D'Amelio R
    Intern Emerg Med; 2016 Feb; 11(1):31-40. PubMed ID: 26099279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute leukemia in rheumatoid arthritis treated with cytotoxic agents.
    Seidenfeld AM; Smythe HA; Ogryzlo MA; Urowitz MB; Dotten DA
    J Rheumatol; 1976 Sep; 3(3):295-304. PubMed ID: 978665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of United States data on neoplasms in rheumatoid arthritis.
    Castor CW; Bull FE
    Am J Med; 1985 Jan; 78(1A):33-8. PubMed ID: 3970038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute leukemia in rheumatoid arthritis treated with cytotoxic agents.
    Seidenfeld AM; Smythe HA; Ogryzlo MA; Urowitz MB; Dotten DA
    J Rheumatol; 1984 Oct; 11(5):586-7. PubMed ID: 6512790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer and rheumatoid arthritis: epidemiologic considerations.
    Prior P
    Am J Med; 1985 Jan; 78(1A):15-21. PubMed ID: 3970036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The immunosuppressive agents in rheumatology. Indications, results and problems of long-term surveillance].
    Kahn MF; De Seze S
    Ann Med Interne (Paris); 1974; 125(6-7):497-506. PubMed ID: 4216281
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rare opportunistic disease in a patient treated with immunosuppressive therapy for rheumatoid arthritis].
    Baixauli Rubio A; Rodríguez Górriz E; Campos Fernández C; Calvo Catalá J; García Vicente S
    An Med Interna; 2003 May; 20(5):276-7. PubMed ID: 12831311
    [No Abstract]   [Full Text] [Related]  

  • 13. Myeloproliferative disorders in patients with rheumatoid arthritis treated with total body irradiation.
    Urowitz MB; Rider WD
    Am J Med; 1985 Jan; 78(1A):60-4. PubMed ID: 3881940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of patients with rheumatoid arthritis treated with immunosuppressive agents between 1965 and 1973].
    Renier JC; Bregeon C; Bonnette C; Boasson M; Bernat M; Basle M; Besson J; Wellinger C; Bourgeois B; Teisseire N
    Rev Rhum Mal Osteoartic; 1978; 45(7-9):453-61. PubMed ID: 725461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of immunosuppressive drugs in the treatment of rheumatoid arthritis].
    Pascual Gómez E
    Med Clin (Barc); 1983 Oct; 81(12):540-4. PubMed ID: 6656371
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
    Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy.
    Genovese MC; Schiff M; Luggen M; Becker JC; Aranda R; Teng J; Li T; Schmidely N; Le Bars M; Dougados M
    Ann Rheum Dis; 2008 Apr; 67(4):547-54. PubMed ID: 17921185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer in the immunosuppressed patient.
    Fahey JL
    Ann Intern Med; 1971 Aug; 75(2):310-2. PubMed ID: 4934281
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer in rheumatoid arthritis: a prospective long-term study of mortality.
    Fries JF; Bloch D; Spitz P; Mitchell DM
    Am J Med; 1985 Jan; 78(1A):56-9. PubMed ID: 3970042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk of acute leukosis after treatment of chronic inflammatory rheumatism and connective tissue inflammation with immunosuppressive cytotoxic drugs. Results of a retrospective study of 2,006 treated patients].
    Kahn MF; Arlet J; Bloch-Michel H; Caroit M; Chaouat Y; Renier JC
    Rev Rhum Mal Osteoartic; 1979 Mar; 46(3):163-7. PubMed ID: 472645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.